China Resources Shuanghe announced that China Resources Shuanghe Xiang Chinese Pharmaceutical Co., Ltd., a holding subsidiary of the company, has received the “Notice of Approval of Application for the Marketing of Chemical Ingredients” for vortioxetine hydrobromide issued by the State Drug Administration. The registration number is Y20250000126, the packaging specification is 3kg/bag, and the status is “A” on the CDE original and auxiliary package registration information disclosure platform. As of the announcement date, the company has invested a total of 9.4891,000 yuan in research and development of this API. The API can be produced and sold to the domestic market after passing the GMP compliance test, which is conducive to enriching the company's product line.

China Resources Shuanghe announced that China Resources Shuanghe Xiang Chinese Pharmaceutical Co., Ltd., a holding subsidiary of the company, has received the “Notice of Approval of Application for the Marketing of Chemical Ingredients” for vortioxetine hydrobromide issued by the State Drug Administration. The registration number is Y20250000126, the packaging specification is 3kg/bag, and the status is “A” on the CDE original and auxiliary package registration information disclosure platform. As of the announcement date, the company has invested a total of 9.4891,000 yuan in research and development of this API. The API can be produced and sold to the domestic market after passing the GMP compliance test, which is conducive to enriching the company's product line.